Virucidal efficacy of a novel silver-based disinfectant against SARS-CoV-2 Omicron BA.5

被引:0
|
作者
Zani, Alberto [1 ]
Messali, Serena [1 ]
Caccuri, Francesca [1 ]
机构
[1] Univ Brescia, Dept Mol & Translat Med, Sect Microbiol, Brescia, Italy
关键词
SARS-CoV-2; Omicron BA; 5; variant; disinfectants; Silver Barrier;
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In this study we evaluated the antiviral activity of the Silver Barrier (R) disinfectant against SARS-CoV-2. Silver Barrier (R) showed time-and concentration-dependent antiviral activity against SARS-CoV-2. After 5 min contact time, Silver Barrier (R) at 0.002% showed a strong inhibitory effect (p < 0.001), with a 2-fold reduction of viral genome copy numbers, and a robust suppression (94%) of SARS-CoV-2 infectivity. Considering the effects obtained in solution and within a very short time, Silver Barrier (R) stands as an excellent new candidate for the disinfection of work environments, especially at the healthcare level, where there are people at high risk of serious illnesses.
引用
收藏
页码:60 / 64
页数:5
相关论文
共 50 条
  • [11] SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern
    Aggarwal, Anupriya
    Akerman, Anouschka
    Milogiannakis, Vanessa
    Silva, Mariana Ruiz
    Walker, Gregory
    Stella, Alberto Ospina
    Kindinger, Andrea
    Angelovich, Thomas
    Waring, Emily
    Amatayakul-Chantler, Supavadee
    Roth, Nathan
    Manni, Sandro
    Hauser, Thomas
    Barnes, Thomas
    Condylios, Anna
    Yeang, Malinna
    Wong, Maureen
    Jean, Tyra
    Foster, Charles S. P.
    Christ, Daniel
    Hoppe, Alexandra Carey
    Munier, Mee Ling
    Darley, David
    Churchill, Melissa
    Stark, Damien J.
    Matthews, Gail
    Rawlinson, William D.
    Kelleher, Anthony D.
    Turville, Stuart G.
    EBIOMEDICINE, 2022, 84
  • [12] Omicron BA.2.75 Subvariant of SARS-CoV-2 Is Expected to Have the Greatest Infectivity Compared with the Competing BA.2 and BA.5, Due to Most Negative Gibbs Energy of Binding
    Popovic, Marko
    BIOTECH, 2022, 11 (04):
  • [13] The Vaccine Efficacy Against the SARS-CoV-2 Omicron: A Systemic Review and Meta-Analysis
    Zou, Yuntao
    Huang, Doudou
    Jiang, Qian
    Guo, Yanglin
    Chen, Chider
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [14] Dynamics of SARS-CoV-2 VOC Neutralization and Novel mAb Reveal Protection against Omicron
    Hao, Linhui
    Hsiang, Tien-Ying
    Dalmat, Ronit R.
    Ireton, Renee
    Morton, Jennifer F.
    Stokes, Caleb
    Netland, Jason
    Hale, Malika
    Thouvenel, Chris
    Wald, Anna
    Franko, Nicholas M.
    Huden, Kristen
    Chu, Helen Y.
    Sigal, Alex
    Greninger, Alex L.
    Tilles, Sasha
    Barrett, Lynn K.
    Van Voorhis, Wesley C.
    Munt, Jennifer
    Scobey, Trevor
    Baric, Ralph S.
    Rawlings, David J.
    Pepper, Marion
    Drain, Paul K.
    Gale, Michael, Jr.
    VIRUSES-BASEL, 2023, 15 (02):
  • [15] Tracking the first SARS-CoV-2 Omicron BA.5.1.3 outbreak in China
    Wang, Xiaoxia
    Zhu, Xiong
    Lin, Yujin
    He, Lvfen
    Yang, Jing
    Wang, Chuan
    Zhu, Wentao
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [16] Epidemiology and analysis of SARS-CoV-2 Omicron subvariants BA.1 and 2 in Taiwan
    Liu, Li-Teh
    Chiou, Shyh-Shin
    Chen, Po-Chih
    Chen, Chun-Hong
    Lin, Ping-Chang
    Tsai, Ching-Yi
    Chuang, Wan-Long
    Hwang, Shang-Jyh
    Chong, Inn-Wen
    Tsai, Jih-Jin
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [17] A machine learning model for predicting serum neutralizing activity against Omicron SARS-CoV-2 BA.2 and BA.4/5 sublineages in the general population
    Camacho, Jorge
    Albert, Eliseo
    Alvarez-Rodriguez, Beatriz
    Rusu, Luciana
    Zulaica, Joao
    Moreno, Alicia Rodriguez
    Peiro, Salvador
    Geller, Ron
    Navarro, David
    Gimenez, Estela
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (04)
  • [18] In silico evaluation of the impact of Omicron variant of concern sublineage BA.4 and BA.5 on the sensitivity of RT-qPCR assays for SARS-CoV-2 detection using whole genome sequencing
    Sharma, Divya
    Notarte, Kin, I
    Fernandez, Rey A.
    Lippi, Giuseppe
    Gromiha, Michael M.
    Henry, Brandon M.
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (01)
  • [19] Antigenic cartography of SARS-CoV-2 reveals that Omicron BA.1 and BA.2 are antigenically distinct
    Mykytyn, Anna Z.
    Rissmann, Melanie
    Kok, Adinda
    Rosu, Miruna E.
    Schipper, Debby
    Breugem, Tim, I
    van den Doel, Petra B.
    Chandler, Felicity
    Bestebroer, Theo
    de Wit, Maurice
    van Royen, Martin E.
    Molenkamp, Richard
    Munnink, Bas B. Oude
    de Vries, Rory D.
    GeurtsvanKessel, Corine
    Smith, Derek J.
    Koopmans, Marion P. G.
    Rockx, Barry
    Lamers, Mart M.
    Fouchier, Ron A. M.
    Haagmans, Bart L.
    SCIENCE IMMUNOLOGY, 2022, 7 (75)
  • [20] Neutralizing Antibodies against the SARS-CoV-2 Delta and Omicron BA.1 following Homologous CoronaVac Booster Vaccination
    Li, Jianhua
    Li, Xiaoyan
    Wang, Erqiang
    Yang, Jinye
    Li, Jiaxuan
    Huang, Chen
    Zhang, Yanjun
    Chen, Keda
    VACCINES, 2022, 10 (12)